| BE0352-1MG
| InVivoMAb anti-mouse E-Cadherin (CD324)
| 1 mg
| BioXCell
| in vivo E-Cadherin neutralization, In vitro E-Cadh
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0324-5MG
| InVivoMAb anti-human/mouse denatured collagen type-I (RGD motif)
| 5 mg
| BioXCell
| Western blot, Immunofluorescence, in vivo administ
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0368-25MG
| InVivoMAb anti-human/mouse/rat amyloid-beta
| 25 mg
| BioXCell
| Western blot, Immunohistochemistry, Immunofluoresc
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0345-25MG
| InVivoMAb anti-mouse/rat/bovine VLDL-R
| 25 mg
| BioXCell
| Western blot
|
| Mouse
| Goat, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0329-25MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 25 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0311-1MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 1 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0303-1MG
| InVivoMAb anti-mouse IL-17F
| 1 mg
| BioXCell
| in vivo IL-17F neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0366-5MG
| InVivoMAb mouse IgG2c isotype control, anti-dengue virus
| 5 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0323-25MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 25 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0332-25MG
| InVivoMAb anti-mouse FGL-1
| 25 mg
| BioXCell
| in vivo FGL-1 blockade, in vitro FGL-1 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0347-25MG
| InVivoMAb anti-human CSF1R (CD115)
| 25 mg
| BioXCell
| in vitro CSF1R neutralization, Immunohistochemistr
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0331-25MG
| InVivoMAb anti-rat/mouse CD71 (TfR1)
| 25 mg
| BioXCell
| Targeted drug delivery to the brain, Immunohistoch
|
| Mouse
| Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0359-1MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope B)
| 1 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0346-25MG
| InVivoMAb anti-mouse CD326 (EpCAM)
| 25 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0354-5MG
| InVivoMAb anti-human CD2
| 5 mg
| BioXCell
| in vivo CD2 blockade in huCD2tg mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0370-100MG
| InVivoMAb anti-human CD71 (TfR1)
| 100 mg
| BioXCell
| Flow cytometry, Immunoprecipitation
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0308-25MG
| InVivoMAb anti-rat CD4
| 25 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0345-50MG
| InVivoMAb anti-mouse/rat/bovine VLDL-R
| 50 mg
| BioXCell
| Western blot
|
| Mouse
| Goat, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0355-25MG
| InVivoMAb anti-human CA19-9
| 25 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0310-50MG
| InVivoMAb anti-mouse VISTA
| 50 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0364-50MG
| InVivoMAb anti-mouse BTLA (CD272)
| 50 mg
| BioXCell
| in vivo BTLA blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0335-5MG
| InVivoMAb anti-human MAGE-C2 (CT10)
| 5 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0361-1MG
| InVivoMAb anti-mouse PD-L1 (B7-H1)
| 1 mg
| BioXCell
| in vivo blocking of PD-L1/CD80 (B7-1) interactions
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0322-5MG
| InVivoMAb anti-mouse CD172a (SIRP?)
| 5 mg
| BioXCell
| in vivo SIRP? blocking, In vitro SIRP? blocking, W
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0369-1MG
| InVivoMAb polyclonal llama IgG
| 1 mg
| BioXCell
|
|
| Llama
|
| Solicitar Precio
| Solicitar
|
| BE0300-1MG
| InVivoMAb anti-mouse CD45.2
| 1 mg
| BioXCell
| Flow cytometry, in vivo CD45.2 blockade, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0336-5MG
| InVivoMAb anti-human MUC1 (CD227)
| 5 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0299-5MG
| InVivoMAb anti-mouse CD200 (OX2)
| 5 mg
| BioXCell
| in vivo CD200 blockade, in vitro CD200 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0337-100MG
| InVivoMAb anti-mouse CD96
| 100 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0369-25MG
| InVivoMAb polyclonal llama IgG
| 25 mg
| BioXCell
|
|
| Llama
|
| Solicitar Precio
| Solicitar
|
| BE0372-25MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 25 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0376-5MG
| InVivoMAb anti-human CD71 (TfR1)
| 5 mg
| BioXCell
| Flow cytometry*, Immunoprecipitation*, Western blo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0375-100MG
| InVivoMAb anti-human EGFR
| 100 mg
| BioXCell
| in vivo EGFR blockade in xenografts, in vitro EGFR
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0301-1MG
| InVivoMAb human IgG2 isotype control
| 1 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0309-1MG
| InVivoMAb anti-mouse CXCL9 (MIG)
| 1 mg
| BioXCell
| in vivo CXCL9 neutralization, Immunofluorescence
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0327-100MG
| InVivoMAb anti-human IL-9
| 100 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0297-100MG
| InVivoMAb human IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0368-5MG
| InVivoMAb anti-human/mouse/rat amyloid-beta
| 5 mg
| BioXCell
| Western blot, Immunohistochemistry, Immunofluoresc
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0340-50MG
| InVivoMAb anti-human/monkey MDR-1 (CD243)
| 50 mg
| BioXCell
| in vivo MDR-1 blocking/depletion in xenogeneic mur
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0302-100MG
| InVivoMAb anti-mouse CD20
| 100 mg
| BioXCell
| Flow cytometry, Western blot, Not recommended for
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0352-100MG
| InVivoMAb anti-mouse E-Cadherin (CD324)
| 100 mg
| BioXCell
| in vivo E-Cadherin neutralization, In vitro E-Cadh
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0307-50MG
| InVivoMAb anti-mouse CD16/CD32
| 50 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0303-50MG
| InVivoMAb anti-mouse IL-17F
| 50 mg
| BioXCell
| in vivo IL-17F neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0371-50MG
| InVivoMAb anti-mouse IL-12 p35
| 50 mg
| BioXCell
| in vivo IL-12 p35 neutralization, in vitro IL-12 p
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0320-50MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 50 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0355-1MG
| InVivoMAb anti-human CA19-9
| 1 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0342-100MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 100 mg
| BioXCell
|
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0321-50MG
| InVivoMAb anti-mouse NKG2A/C/E
| 50 mg
| BioXCell
| in vivo NKG2A blockade (see description), in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0374-1MG
| InVivoMAb anti-mouse FAP
| 1 mg
| BioXCell
| Chimeric antigen receptor construction, Flow cytom
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0325-100MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 100 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|